Lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia, MYD88 L265P with reflex to CXCR4

Alphabetical Test listing

Lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia, MYD88 L265P with reflex to CXCR4-994

  
Lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia, MYD88 L265P with reflex to CXCR4
  
994
  
LAB994
  
MSO
  
B-cell lymphoma
L265P
LPL/WM
Lymphoplasmacytic lymphoma
MYD88
CXCR4
Waldenstrom Macroglobulinemia
CXLPL
S338X
  
The algorithm starts with the sensitive MYD88 L265P testing by allele-specific polymerase chain reaction.

If a MYD88 L265P variant is detected, additional CXCR4 testing will be performed.
If a MYD88 L265P variant is not detected, the algorithm ends and no further testing is necessary.
  
  • Establishing the diagnosis of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia (LPL/WM)
  • Helping distinguish LPL/WM low-grade B-cell lymphoma from other subtypes
  • Aiding in the prognostication and clinical management of LPL/WM
  
Bone marrow
  
  
2 mL
  
  1. Invert several times to mix bone marrow
  2. Label specimen as bone marrow
  

Send bone marrow specimen in original tube. Do not aliquot.

 

  

Lavender (EDTA), 4mL

 

  
ACD whole blood, peripheral
  

Yellow top (ACD solution B)

  
3.0 mL
  
  1. Invert several times to mix blood
  2. Label specimen as peripheral blood
  

Send whole blood specimen in original tube. Do not aliquot.

  
  • Pertinent clinical history
  • Clinical or morphologic suspicion
  • Date and time of collection
  • Specimen source

 

Molecular Medicare Billing Request

Hospital clients submitting a request for this assay on an outpatient with Medicare should complete and submit a Molecular Medicare billing request form to notify us of the need for Allina Health Laboratory to bill insurance.

  

Ambient (preferred) - 10 days

Refrigerate - OK

  
2 weeks
  
  • Gross hemolysis
  • Clotted
  
Mayo Clinic Laboratories (LPLFX): R-NX
  
Mo - Fr
  
7 - 10 days
  

Allele-Specific Polymerase Chain Reaction (AS-PCR), Bridged Nucleic Acids (BNA) Clamp Sanger Sequencing and routine Sanger Sequencing

  

Reportable variant present or not detected.

An interpretive report will be provided.

  
This test may require preauthorization from the insurance provider. Check the payer guidelines and, if needed, obtain the pre-authorization prior to sample collection.
  
81305
  
Yes
  

Medical necessity

Hospital clients submitting a request for this assay on an outpatient with Medicare should complete and submit a Molecular Medicare billing request form to notify us of the need for Allina Health Laboratory to bill insurance.

Molecular Medicare Billing Request

  
04/30/2019
  
05/23/2024
  
05/06/2022